Abadan, Melanie U.

HRN: 09-66-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
CO-AMOXICLAV 625MG (TAB)
03/21/2026
03/27/2026
PO
625mg
TID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: